Latest operating income for ZOM: $-21M.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
Zomedica (ZOM) currently reports a operating income of $-21M as of June 2026. That compares with $-88M in the prior-year period — up 76.5% year over year. Use the charts on this page to explore Zomedica's operating income history and peer comparisons.
Zomedica's operating income increased from $-88M to $-21M — a 76.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Zomedica reported $-21M in operating income as of June 2026. That compares with $-88M in the prior-year period — up 76.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current operating income of $-21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zomedica, and consider following ZOM for alerts when major investors trade the stock.
Zomedica is classified in the Healthcare sector. On operating income, it currently shows $-21M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZOM with unrelated industries.